chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First Moderna dose on 3/30/2021 had no apparent adverse effects.  Patient has persistent low platelet count, which dropped then recovered after the first dose without causing ITP symptoms.  Second dose on 4/27/2021: significant muscle pain at injection site starting 8 hours after injection, lasting for 12 hours then subsiding.  Significant chills/shivering starting 12 hours after injection, then fever of 102 with body aches and unsteady movement rising and subsiding over 36 hours.  Moderate throat irritation and productive cough for 4 hours.  Fully recovered from all physical effects by 48 hours after injection. Platelet response similar to first dose, lowered count with no ITP symptoms.
Sore/swollen arm, headaches/migraines (continuous since shot), chills, nausea, fatigue, muscle aches, swollen lymph nodes under arm and in neck, all symptoms still ongoing on 3/26/2021. Wheezing (on 3/24/2021 all evening, but not on following days)
7/2/2022, 8 hours after right arm rabies shot, started with left sided facial  numbness and tingling, which went away by 7/3/2022. On 7/6/2022 after right  arm rabies shot, started  with right sided facial numbness and tingling, and as of this date 7/13/2022, it has not gone away.  7/13/2022 they gave me the last rabies hot in my left hip.  hospital could not provide the lot number of the 2 arm shots, but gave me the lot number of the hips shot. Rabavert lot YRBA831B. 2 hours later, there are (so far) no numbness from the  hip shot. Hospital infusion lab supervisor had never heard of the VAERS report and said the probably wouldn't do one. Last week, Allegheny Health Board supervisor instructed me to make my own report, that the hospital might not do it.
Erythema color covering entire anterior thigh tx with BACTRIM; BENADRYL.
She stated with the first Pfizer COVID vaccine, she only had a headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2 (BNT162B2), on 13Feb2021 as dose 1, single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hashimoto's" (unspecified if ongoing), notes: Hashimoto's diagnosed many years ago and prior to receiving any of the Pfizer COVID vaccines.; "allergies to medicine" (unspecified if ongoing), notes: She has many allergies to medicine. There were no concomitant medications. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "She stated with the first Pfizer COVID vaccine, she only had a headache".  Additional information: The patient also received BNT162b2 on 06Mar2021 as dose 2, on 12Nov2021 as dose 3, on 08Apr2022 as dose 4, in left arm for covid-19 immunisation. The patient also received diphtheria and tetanus vaccine on 28Sep2022. She had Hashimoto's which was diagnosed many years ago and prior to receiving any of the Pfizer COVID vaccines. She had many allergies to medicine and needs to know when they change something. She had a lot of medicines she was allergic to. She did not wish to provide details about those medications because she stated it was lengthy. No other conditions and investigations reported. Family medical history relevant to adverse events were none. She stated with the first Pfizer COVID vaccine, she only had a headache. She did not have the lot or expiration for that one.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Headache (9 days), fever for over 1 week (low-grade), injection site pain (7 plus days)
Arm soreness at injection site, swelling in arm at injection site, headache, dizziness, exhaustion
Decreased air movement present/Examination of the right-upper field reveals decreased breath sounds and wheezing. Examination of the left-upper field reveals decreased breath sounds and wheezing; wheezing/Tight wheeze in lungs; difficulty breathing/shortness of breath; chest tightness; phlegmy throat; frequent throat clearing; This is a spontaneous report from a non-contactable other health care professional. A 48-year-old female patient received second dose of BNT162B2 via an unspecified route of administration on 17Mar2021 (Lot Number: EN6205) as a single dose for covid-19 immunization. The patient medical history was not reported. Patient previously received 1st dose of BNT162B2 on an unspecified date for COVID-19 immunization. The patient's concomitant medications were not reported. During patient's 15 minute waiting period after the injection on 17Mar2021, the patient began to experience difficulty breathing, and chest tightness and phlegmy throat. Patient complained of frequent throat clearing, chest tightness and shortness of breath. Breath sounds: Decreased air movement present. Examination of the right-upper field reveals decreased breath sounds and wheezing. Examination of the left-upper field reveals decreased breath sounds and wheezing. Decreased breath sounds and wheezing present. No rhonchi or rales. Comments: Tight wheeze in lungs. Events cleared after 2 puffs of albuterol inhaler, symptoms reoccurred within 10 min of use. Treatment included albuterol, antihistamines, oral steroids, water and Pepcid. She had poor follow up response to treatment. Patient discharge and transported to ED by ambulance. The outcome of events was unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.
comples febrile seizure 12 hrs p/vax; seen in ER given DIlantin; hx of agenesis corpus callosum, global developmental delay, bilat mastoidectomy, sz disorder;
Major side effect: Paralysis in left foot. Weak left leg.  Second vaccine - Jan 28, 2021 at 4:00 PM. Typical side effects were noticed on Jan 29, that being chills, fever, dizziness, weakness in both legs, itchy arm at vaccine site.  Jan 30 side effects were dizziness, stumbly, chills and trouble walking with left leg.  Legs were still weak, left was worse. I had paralysis in my left foot. My left foot would not move back, only forward so when I walked my toes drug the ground.  I called Doctor.  He told me to see a neurologist and go to ER if symptoms progressed.  I have made the appointment for Feb 16, 2021. Foot is slowly improving. Left leg is still weak and there is some numbness in left leg and left foot.
The first two weeks after vaccination it felt like my body was super hot. I couldn't tolerate the heat or clothing and I was sweating a lot. I had fatigue and weakness especially in my joints. The second week the symptoms continued and now I had joint pain in my large joints, like my knees and hips. I had no strength in my hands. I tried to lift something and I felt a burning sensation in my palms. The third week, the symptoms from the first two weeks persisted and I had swelling in my hands, it was painful to type or use my hands to eat or brush my teeth.
Information has been received from a registered nurse (RN) concerning a 4 year old male student with an allergy to amoxicillin (AMOXIL) who on 14-AUG-2001 was vaccinated in the left arm with the first dose of varicella virus vaccine live (lot#637667/1606K). Concomitant vaccinations on that same day included the first dose in the right arm of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (Lot#637834/0696L). There was no illness at the time of vaccination. The RN reported that on 15-JUL-2005, the patient developed breakthrough characterized by 60 - 100 spots. The patient was noted to be afebrile. No office or hospital visit or laboratory/diagnostic tests were required and the patient was advised to treat his symptoms. On 23-JUL-2005, the patient recovered from the breakthrough. The RN also reported that the patient's brother developed chickenpox after being vaccinated with varicella virus vaccine live (WAES0507USA04242). No further information is available.
sore calves & thighs, some neck soreness, weakness of lips-unable to whistle;
Information has been received from a licensed practical nurse, concerning a patient of an unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medication were not reported. On an unknown date, the patient was vaccinated with an unspecified dose of PROQUAD lot number: M002053 with expiration date of 11-JUL-2017 (dose, dose number, anatomical location and route of administration were not provided) for prophylaxis, reconstituted with an sterile diluent (DILUENT MRK) (indication, formulation, strength, dose, route of administration, lot number and expiration date were not provided).  On the same date, the patient was also vaccinated with an unspecified dose of VARIVAX lot number: L049532 with expiration date of 08-DEC-2017 (dose, anatomical location and route of administration were not provided) for prophylaxis, reconstituted with an sterile diluent (DILUENT MRK) (indication, formulation, strength, dose, route of administration, lot number and expiration date were not provided). No adverse effects were reported. Additional information has been requested.
Patient was given 0.25mcg Moderna Bivalent Booster not 0.5mcg. Wrong dose was given.
Sore arm; Upset stomach; Redness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY, ABDOMINAL DISCOMFORT, and VACCINATION SITE ERYTHEMA in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY, ABDOMINAL DISCOMFORT, and VACCINATION SITE ERYTHEMA. At the time of the report, PAIN IN EXTREMITY, ABDOMINAL DISCOMFORT, and VACCINATION SITE ERYTHEMA outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. The patient did not take any treatment medication.   This case was linked to MOD-2021-209267.
A female patient of reported unknown age had received a left deltoid, intramuscular injection of FLUZONE SV 2007-2008, lot number U2464AA, on 29 October 2007. Needle used was a 27 gauge with a 1.5 inch length. On the same day, the patient developed spontaneous, intermittent twitching of the left arm. There was no pain or soreness. The event did not require medical examination. At the time of this report, the patient had not recovered. The reporter in this case is the same as in case 2007-03692.
Tiredness; muscle pain; joint pain; fever; feeling unwell; fast heartbeat; This is a spontaneous report from a contactable consumer (patient).   A 73-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number was not reported), via an unspecified route of administration, administered in arm left on 03Mar2021 at 09.00 (73-year-old at the time of vaccination) as dose 2, single for covid-19 immunization at doctor's office/urgent care. The patient was not pregnant at time of vaccination. The patient's medical history included allergy to Penicillin. The patient's specific concomitant medications name were not reported. It was reported that the patient had other medications in two weeks (not specified). Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot number was not reported), via an unspecified route of administration administered in left arm on 10Feb2021 at 09.15 (73-year-old at the time of vaccination) as dose 1, single for covid-19 immunisation. The patient had not received any vaccine within four weeks. The patient had no covid prior to vaccination. The patient was not tested since vaccination. On 03Mar2021 at 20.00, the patient experienced tiredness, muscle pain, joint pain, fever, feeling unwell and fast heartbeat. No treatment was received for the events. The patient underwent lab tests and procedures which included heartbeat: fast, on an unspecified date. The outcome of the events was recovered on an unspecified date in Mar2021.   No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Severe red rash upper body,  pancreatitis, digestive distress, severe fatigue
I had an abscess tooth that became infected; UTI; headache; stomach bloating; pressure and discomfort; blood in my urine; This is a spontaneous report from a contactable consumer (patient herself). A 52-year-old female received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 18Jan2021 at 10:30 AM as a single dose for COVID-19 immunization. The patient had no relevant medical history. The patient ha d no allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination, has not been tested for COVID-19 since the vaccination, and was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine and also did not receive any other medication within two weeks of vaccination. The patient had a headache on 22Jan2021 for 5 days. She also had stomach bloating and pressure and discomfort on 22Jan2021. It was reported that when she saw blood in her urine, she went to a walk-in and was diagnosed with a UTI on 22Jan2021. She did 7 days of an antibiotic. Then on 30Jan2021, she had an abscess tooth that became infected. It was reported that the patient received antibiotics for both infections. It was reported that the events result in a doctor or other healthcare professional office/clinic visit and an Emergency room/department or urgent care. Outcome of the events was recovering. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect).
Heart pain periodically, definitely fluttering, palpitations-felt like I was going to have a heart attack. Cannot sustain running as usual.
Night sweats, chills and shaking (violently at times), low-grade fever, body aches, severe pain at injection site lasting 3 days,  slight shortness of breath at times, elevated heart rate, lethargy, headache.
Warm, raised, red 4 cm x 2 cm area above site where Zostavax was given on right arm. No other symptoms reported.
Start with reactions on 10.26.22 with soreness under the right arm.  10.27 started with swelling in arm pit and supraclavicular area along with soreness.  Swollen Lymph nodes. States this happened when got last COVID vaccine 1/2021.
Information has been received from a physician concerning a female (unknown age) with an unspecified history and allergies reported, who on an unspecified date was vaccinated with a 0.5 dose of Gardasil.  The lot number was not reported.  Subsequently, on an unknown date the patient experienced a knot at the injection site.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information has been requested.
This is a spontaneous report from a contactable nurse. A 55 year-old female patient received on 15Jul2015 a single dose of PREVNAR 13 (lot/batch number L62075, expiry date Dec2016, NDC number: 0005197102) intramuscular in the right deltoid. Relevant medical history included regular hypercholesterol, depression and thyroid problems. Concomitant medications included: NEXIUM at 40 mg, SYNTHROID at 50 ug, MIRAPEX (tablet) 0.25 mg, (one to two tablet), PROAIR, XANAX at 0.5 mg, BREO ELLIPTA. The patient experienced cellulitis in the right arm where she received vaccine at site of injection and lymph node swelling in the right axis (axillary and epitrochlear) on 19Jul2015. The patient took amoxicillin for the treatment of the events and she did not perform laboratory works. The patient recovered from the events on unknown date. The nurse was sure that the vaccine caused the cellulitis and lymph node swelling because it was after she got the vaccine. The nurse mentioned that as of now patient was not suffering from these events. Causality: The nurse mentioned all these adverse events were due to PREVNAR 13.
After injection, pt became diaphoretic and pale and dizzy. Pt lost balance and fell to ground. No loss of consciousness.
Immediately: bled at injection site, hard lump with redness and swelling, elevated blood pressure, a bit disoriented, pharmacist called EMT for evaluation Day 2: Headache, fatigue Day 3: Headache, fatigue, sinusy Day 4: Headache, fatigue, I feel like I have a cold Day 5: Headache, fatigue, weird sensation in feet Day 6:Severe headache, slight nausea, chills, no fever, fatigue, developed "new looking" bruise at injection site, arm sore for remainder of day Day 7: Feet cold, heavy, tingly. Headache and fatigue continue Day 8: Woke up w/ achy legs. achiness subsided, but feet continue to hurt. not moving upwards. Headache, fatigue continue. Day 9: same as yesterday, but a bit more energy. First day of feeling a bit better. Headache, fatigue continue Day 10: Feet continue to hurt, not moving upward.  Headache, fatigue continue
mom called 14JUN96 930AM to say pt had t104.3 12JUN96 during noc has enlarged nodes in neck & groin w/large red spots on body today & anorexia;3AUG96 called MD office reported s/s d/t viral illness not r/t vax;
could not get the 2nd due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in late 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The reporter was the patient's husband. The age at vaccination was not applicable for this report. The pharmacist reported that, the patient did not receive 2nd dose of Shingrix due to COVID, which led to social problem. The reporter asked if need to restart again. This case was linked with case US2021AMR183042, reported same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183042:Same reporter
reaction post Pfizer booster last week on Thursday 11/4/21. Patient states had soreness to injection site Thursday to Saturday, improving each day to just a few twinges on Saturday. States had fever(did not take temp) with chills and inner thigh discomfort and achy starting Thursday evening and improving late in day Friday. Patient states first noticed had "weakness in hands" Friday am, had difficulty holding pencil and trouble focusing , felt mind was wandering. Took Advil for discomfort x 2. States other symptoms improved Saturday except hand weakness still present and then on Sunday patient felt back to normal self.
Shortness of breath, Fatigue, muscle aches, chest pain, dizzy and light headed, headache
COVID-19 SYMPTOMS; OFF LABEL DOSING FREQUENCY; This spontaneous report received from a patient via other manufacturer Pfizer concerned a 30 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: drug allergy (drug not reported). The patient previously took covid-19 vaccine ad26.cov2.s (Dose number in series 1) (unspecified manufacturer) (suspension for injection, route of admin was not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, start date was not reported administered for prophylactic vaccination. It was unknown whether the patient experienced any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, administered on 28-APR-2021 for prophylactic vaccination which was off label use (off label dosing frequency) (Dose number in series 2). Age at time of vaccination 30 years old. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-JUN-2022, the patient initiated the treatment with paxlovid for COVID-19 and completed the treatment on 10-JUN-2022. On an unspecified date in JUN-2022, the patient experienced covid-19 symptoms after treatment with paxlovid (Dose number in series 2). On an unspecified date in JUN-2022, Laboratory data included: COVID-19 virus test Positive (the patient had strong positive at home test). The action taken with covid-19 vaccine ad26.cov2.s was not applicable and with paxlovid was drug discontinued. The patient had not recovered from covid-19 symptoms, and the outcome of off label dosing frequency was not reported. This report was non-serious. This report was associated with product quality complaint: 90000238707.; Sender's Comments: V0-Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Per mother, pt stopped talking and interacting with parents 24-36 hrs after receiving vaccines on 04/20/00. Mother told pediatrician, who said he was reacting to the birth of his sister (born 03/08/00). Missing vaccine information the mother related this information well after the fact . Since health dept did not give the immunizations we have no access to the manufacturer or lot number of vaccines given.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received BNT162b2 (BNT162B2), on 21Jan2021 at 13:00 as dose 1, single (Batch/Lot number: unknown), in right arm, on 11Feb2021 at 00:30 as dose 2, single (Batch/Lot number: unknown), in right arm, on 09Nov2021 at 13:30 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm and on 20Apr2022 at 14:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 71 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing), notes: Other medical history: Type 1 diabetes as of 3 years. The patient had no Known allergies. There were no concomitant medications/no Other medication in 2weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (17Jul2022) Negative, notes: After having been tested negative for COVID on Sunday 17Jul and Monday 18Jul; (18Jul2022) Negative, notes: After having been tested negative for COVID on Sunday 17Jul and Monday 18Jul; (24Jul2022) Positive, notes: tested myself again today on 24Jul and was positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient started treatment with Anti-viral details included: Brand: Paxlovid, Treatment start date: 14Jul2022, Treatment stop date: 18Jul2022  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After 8 days a large , about 6-8 inches,  red rash appeared at the injection site. It was tender to the touch for the first several days, and then the rash appeared for about a week.  The rash disappeared with not other side effects.I received the second dose on  2/18/2021 and have tenderness,  slight swelling in arm and red rash about the size of  a quarter. I have not reported this to my physician or the pharmacy.